Relugolix CT Trial for Endometriosis Pain
Phase 3
130
about 2.8 years
18–49
Female only
1 site in MI
What this study is about
This trial is testing if Relugolix Combination-Therapy (CT) can reduce pelvic pain, inflammation, and pain sensitivity in women with moderate-to-severe endometriosis associated pelvic pain. The treatment will last 1035 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Relugolix CT
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change score for functional magnetic resonance imaging (fMRI) connectivity of the somatosensory cortices to the default-mode network
Secondary: Change scores for pelvic pain interference
Reproductive Health